TRIP13 and colorectal carcinoma: In this study, we used multiple methods to demonstrate that TRIP13 can promote CRC cell proliferation, migration, and invasion in vitro and subcutaneous implanted tumor formation in vivo, and it predicted poor survival of CRC patients.